Research & Publications

1
EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer
Impact Factor:14.1
Journal:Advanced Science
Publication Date:2026-09-14
2
Histone Lactylation Mediated by circRNA-Facilitated FXR1 Phase Separation Promotes Colorectal Cancer Progression
Impact Factor:22.6
Journal:Cancer Research
Publication Date:2026-08-27
3
Farnesylation-driven KRAS phase separation promotes colon tumor growth
Impact Factor:45.1
Journal:Cell
Publication Date:2026-08-24
4
Discovery, Optimization, and Biological Evaluation of 2-Cyano-2(9H-xanthen-9-ylidene)acetamide Derivatives as ZNF207 Inhibitorsfor Anti-Glioma Therapy
Impact Factor:6.8
Journal:Journal of Medicinal Chemistry
Publication Date:2026-03-19
5
Renshen-Baidu-San restores epithelial–immune crosstalk and drives type 2 immune repair in ulcerative colitis: an integrated multi-omics study
Impact Factor:5.9
Journal:Frontiers in Immunology
Publication Date:2026-03-11
6
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer
Impact Factor:10.1
Journal:Cancer Letters
Publication Date:2026-02-23
7
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
Impact Factor:28.5
Journal:Nature Cancer
Publication Date:2026-01-29
8
Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation
Journal:Cellular Oncology
Publication Date:2026-01-06
9
Targeting CAMK1D-engineered nanoactivator suppresses cancer stem cell maintenance and immune evasion in enzalutamide-resistant prostate cancer
Impact Factor:13.3
Journal:Theranostics
Publication Date:2026-01-01
10
Cetobacterium somerae ZNN-1 promotes goblet cell differentiationthrough glutamine-mediated Notch signaling suppression
Impact Factor:13
Journal:Journal of Advanced Research
Publication Date:2025-12-28

AimingMed is a leading biotech company specializing in organoid technology.Our techniques empower oncologist with organoid-based drug sensitivity tests, and our AI algorithm facilitate the selection of the most suitable treatment options for patients...

Services

Contact

  • Hangzhou AimingMed Technologies Co., Ltd.
    1st Floor, South Block, Building 10, No.88 Jiangling Road, Binjiang District, Hangzhou, Zhejiang Province, P.R.China
  • Chengdu AimingMed Medical Laboratory Co., Ltd.
    1st Floor, Building 5, No.77 Jinke South Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province
  • Chengdu Organoids Biobank
    No.1, 1st Floor, Building 5, No.77, Jinke South Second Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province, China
  • Shandong Province Organoids Biobank
    Building 16, Blue Medicine Valley Life Island, No. 17, Donghai Road, Dayao Subdistrict, Muping District, Yantai City, Shandong Province, China
  • AimingMed Singapore Pte.Ltd.
    CSSD International Business Cooperation Centre, BLK 55 Ayer Rajah Crescent #01-01, Singapore 139949
  • 0571-85352695
  • info@aimingmed.com